Actively Recruiting
An Open-label, Randomized Study Comparing Patritumab Deruxtecan Versus Physician's Choice in Treating Hormone Receptor-positive, HER2-negative Advanced or Metastatic Breast Cancer
Led by Merck Sharp & Dohme LLC · Updated on 2026-06-08
1000
Participants Needed
182
Research Sites
N/A
Total Duration
On this page
Sponsors
M
Merck Sharp & Dohme LLC
Lead Sponsor
D
Daiichi Sankyo
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are evaluating new treatments for hormone receptor-positive, HER2-negative breast cancer that cannot be removed by surgery or has spread to other parts of the body. This study focuses on patients whose cancer has either locally advanced or metastatic disease and have previously received specific hormone and targeted therapies. The goal is to see if treatment with patritumab deruxtecan can help patients live longer or delay cancer progression compared to other chemotherapy options or trastuzumab deruxtecan. Participants are randomly assigned to receive either patritumab deruxtecan through intravenous infusion every three weeks for about 13 months or a treatment chosen by their doctor, which may include various chemotherapy drugs or trastuzumab deruxtecan. The study treatment options in the doctor’s choice group are given on different schedules, such as weekly or every three to four weeks, depending on the drug selected. Throughout the study, participants will be closely monitored with regular assessments to measure progression-free survival and overall survival for up to approximately 45 and 85 months respectively. Researchers will also evaluate tumor response, quality of life using specific questionnaires, and track any side effects. The study includes long-term follow-up to understand the impact of treatment over time and ensure participant safety.
CONDITIONS
Brief Title
A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 18 years and older
- Diagnosed with hormone receptor-positive (HR+) and HER2-negative (HER2-) invasive breast cancer that is unresectable locally advanced or metastatic
- Centrally confirmed HR+ and HER2- status and evaluable HER3 results from a recent biopsy
- Progression or recurrence after treatment with CDK4/6 inhibitor plus endocrine therapy
- Measurable disease per RECIST 1.1 criteria
- Well-controlled HIV infection if present
- Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 within 7 days before randomization
You will not qualify if you...
- Breast cancer that can be treated with curative intent
- Eligible for additional endocrine therapy in the advanced setting
- Known harmful BRCA gene mutation where PARP inhibitors are a treatment option
- Current or impending visceral crisis causing organ compromise or life-threatening conditions
- Pulse oximetry reading below 92% at rest or need for supplemental oxygen
- Uncontrolled significant cardiovascular or cerebrovascular disease
- Peripheral neuropathy of grade 2 or higher
- Clinically significant corneal disease
- Previous chemotherapy for unresectable locally advanced or metastatic breast cancer
- Prior treatment with anti-HER3 antibody-drug conjugates or topoisomerase I inhibitors
- Recent systemic anticancer therapy within 4 weeks before randomization
- Recent radiotherapy for non-central nervous system disease within 14 days before study treatment
- Immunodeficiency or ongoing systemic steroid therapy
- Active additional malignancy requiring treatment within the past 3 years
- History or current pneumonitis/interstitial lung disease requiring steroids or suspected but unconfirmed by imaging
- Severe hypersensitivity to patritumab deruxtecan or any treatment of physician's choice agents or their components
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to approximately 13 months
Participants receive either patritumab deruxtecan via intravenous (IV) infusion every 3 weeks for approximately 13 months or treatment of physician's choice, which includes various chemotherapy options administered on different schedules for up to 13 months.
IV infusion visits every 3 weeks or chemotherapy visits according to the chosen treatment schedule
Duration - Up to approximately 85 months
Participants are monitored for disease progression, overall survival, and quality of life for up to approximately 85 months after treatment.
Periodic visits for assessments and monitoring
Trial Site Locations
Total: 182 locations
1
Southern Cancer Center (SCC) ( Site 8000)
Daphne, Alabama, United States, 36526
Actively Recruiting
2
The University of Arizona Cancer Center - North Campus ( Site 0055)
Tucson, Arizona, United States, 85719
Actively Recruiting
3
Los Angeles Hematology Oncology Medical Group ( Site 0026)
Los Angeles, California, United States, 90017
Actively Recruiting
4
Hoag Memorial Hospital Presbyterian ( Site 0025)
Newport Beach, California, United States, 92663
Actively Recruiting
5
St. Marys Hospital and Regional Medical Center-SCL Health Cancer Centers of Colorado ( Site 0021)
Grand Junction, Colorado, United States, 81501
Actively Recruiting
6
Medical Oncology Hematology Consultants (MOHC) ( Site 8002)
Newark, Delaware, United States, 19713
Actively Recruiting
7
Comprehensive Hematology Oncology ( Site 0060)
St. Petersburg, Florida, United States, 33709
Actively Recruiting
8
Baptist Health Lexington ( Site 0050)
Lexington, Kentucky, United States, 40503
Actively Recruiting
9
Baptist Health Hamburg ( Site 0071)
Lexington, Kentucky, United States, 40509
Actively Recruiting
10
John Theurer Cancer Center at Hackensack University Medical Center ( Site 0001)
Hackensack, New Jersey, United States, 07601
Actively Recruiting
11
Rutgers Cancer Institute of New Jersey ( Site 0033)
New Brunswick, New Jersey, United States, 08903
Actively Recruiting
12
Presbyterian Kaseman Hospital ( Site 0072)
Albuquerque, New Mexico, United States, 87110
Actively Recruiting
13
University of New Mexico Comprehensive Cancer Center ( Site 0047)
Albuquerque, New Mexico, United States, 87131
Actively Recruiting
14
Presbyterian Rust Jorgensen Cancer ( Site 0073)
Rio Rancho, New Mexico, United States, 87124
Actively Recruiting
15
Queens Hospital Cancer Center ( Site 0011)
Jamaica, New York, United States, 11432
Actively Recruiting
16
Optum Medical Care, PC ( Site 0009)
Westbury, New York, United States, 11590
Actively Recruiting
17
Novant Health Cancer Institute ( Site 0019)
Charlotte, North Carolina, United States, 28204
Actively Recruiting
18
Novant Health Oncology Specialists ( Site 0074)
Winston-Salem, North Carolina, United States, 27103
Actively Recruiting
19
TriHealth Cancer Institute-Good Samaritan Hospital ( Site 0020)
Cincinnati, Ohio, United States, 45220
Actively Recruiting
20
University of Pittsburgh Medical Center Magee-Womens Hospital ( Site 0058)
Pittsburgh, Pennsylvania, United States, 15213
Actively Recruiting
21
Cancer Care Associates Of York ( Site 0063)
York, Pennsylvania, United States, 17403
Actively Recruiting
22
SCRI Oncology Partners ( Site 7000)
Nashville, Tennessee, United States, 37203
Actively Recruiting
23
Tennessee Oncology, PLLC ( Site 0068)
Nashville, Tennessee, United States, 37203
Actively Recruiting
24
Texas Oncology - DFW ( Site 8003)
Dallas, Texas, United States, 75246
Actively Recruiting
25
JPS Health Network ( Site 0067)
Fort Worth, Texas, United States, 76104
Actively Recruiting
26
Texas Oncology - Gulf Coast ( Site 8006)
Houston, Texas, United States, 77024
Actively Recruiting
27
Oncology Consultants P.A. ( Site 0061)
Houston, Texas, United States, 77030
Actively Recruiting
28
Texas Oncology - Central/South Texas ( Site 8005)
McAllen, Texas, United States, 78503
Actively Recruiting
29
Mays Cancer Center ( Site 0049)
San Antonio, Texas, United States, 78229
Actively Recruiting
30
Virginia Oncology Associates (VOA) ( Site 8001)
Norfolk, Virginia, United States, 23502
Actively Recruiting
31
Shenandoah Oncology ( Site 8004)
Winchester, Virginia, United States, 22601
Actively Recruiting
32
Northwest Medical Specialties, PLLC ( Site 0062)
Tacoma, Washington, United States, 98405
Actively Recruiting
33
Circuit Clinical/SSM Health Dean Medical Group ( Site 0039)
Madison, Wisconsin, United States, 53715
Actively Recruiting
34
Hospital Aleman ( Site 0200)
Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina, C1118AAT
Actively Recruiting
35
Instituto de Investigaciones Clínicas Mar del Plata ( Site 0205)
Mar del Plata, Buenos Aires, Argentina, B7600FZO
Actively Recruiting
36
Fundación Respirar ( Site 0201)
Buenos Aires, Buenos Aires F.D., Argentina, C1426AAL
Actively Recruiting
37
Centro Privado de RMI Rio Cuarto ( Site 0207)
Río Cuarto, Córdoba Province, Argentina, X5800ALB
Actively Recruiting
38
Instituto de Oncología de Rosario ( Site 0208)
Rosario, Santa Fe Province, Argentina, S2000KZE
Actively Recruiting
39
Instituto Alexander Fleming ( Site 0202)
CABA, Argentina, C1426DRB
Actively Recruiting
40
Hospital Italiano de Córdoba ( Site 0206)
Córdoba, Argentina, X5004BAL
Actively Recruiting
41
Blacktown Hospital-Blacktown Cancer and Haematology Centre - Medical Oncology ( Site 2300)
Blacktown, New South Wales, Australia, 2148
Actively Recruiting
42
Chris O'Brien Lifehouse ( Site 2302)
Camperdown, New South Wales, Australia, 2050
Actively Recruiting
43
Monash Medical Centre ( Site 2301)
Clayton, Victoria, Australia, 3168
Actively Recruiting
44
The Alfred Hospital ( Site 2305)
Melbourne, Victoria, Australia, 3004
Actively Recruiting
45
Hospital de Câncer de Recife ( Site 0302)
Recife, Pernambuco, Brazil, 50040-000
Actively Recruiting
46
Liga Norte Riograndense Contra o Câncer ( Site 0301)
Natal, Rio Grande do Norte, Brazil, 59062-000
Actively Recruiting
47
Hospital do Câncer Mãe de Deus ( Site 0300)
Porto Alegre, Rio Grande do Sul, Brazil, 90470-340
Actively Recruiting
48
Instituto de Oncologia Saint Gallen ( Site 0308)
Santa Cruz do Sul, Rio Grande do Sul, Brazil, 96830-180
Actively Recruiting
49
ANIMI - Unidade de Tratamento Oncologico ( Site 0306)
Lages, Santa Catarina, Brazil, 88501-001
Actively Recruiting
50
Hospital Paulistano ( Site 0304)
São Paulo, Brazil, 01321-001
Actively Recruiting
51
The Moncton Hospital ( Site 0101)
Moncton, New Brunswick, Canada, E1C 6Z8
Actively Recruiting
52
Sunnybrook Research Institute ( Site 0105)
Toronto, Ontario, Canada, M4N 3M5
Actively Recruiting
53
CIDO SpA ( Site 0408)
Temuco, Araucania, Chile, 4810218
Actively Recruiting
54
FALP ( Site 0400)
Santiago, Region M. de Santiago, Chile, 7500921
Actively Recruiting
55
Oncovida ( Site 0402)
Santiago, Region M. de Santiago, Chile, 7500994
Actively Recruiting
56
Centro de Oncología de Precisión ( Site 0410)
Santiago, Region M. de Santiago, Chile, 7560908
Actively Recruiting
57
Clínica MEDS La Dehesa ( Site 0405)
Santiago, Region M. de Santiago, Chile, 7691236
Actively Recruiting
58
Bradfordhill ( Site 0401)
Santiago, Region M. de Santiago, Chile, 8420383
Actively Recruiting
59
Anhui Provincial Cancer Hospital ( Site 3140)
Hefei, Anhui, China, 230088
Actively Recruiting
60
Cancer Hospital Chinese Academy of Medical Sciences ( Site 3100)
Beijing, Beijing Municipality, China, 100021
Active, Not Recruiting
61
Peking University People's Hospital ( Site 3138)
Beijing, Beijing Municipality, China, 100044
Actively Recruiting
62
The First Affiliated Hospital of Chongqing Medical University ( Site 3101)
Chongqing, Chongqing Municipality, China, 400016
Actively Recruiting
63
Chongqing Three Gorges Central Hospital's ( Site 3128)
Wanzhou, Chongqing Municipality, China, 404000
Actively Recruiting
64
The First Affiliated hospital of Xiamen University ( Site 3120)
Fujian, Fujian, China, 361003
Actively Recruiting
65
Sun Yat-Sen University Cancer Center ( Site 3102)
Guangzhou, Guangdong, China, 510060
Actively Recruiting
66
Jiangmen Central Hospital ( Site 3132)
Jiangmen, Guangdong, China, 529000
Actively Recruiting
67
Guangxi Medical University Affiliated Tumor Hospital ( Site 3118)
Nanning, Guangxi, China, 530021
Actively Recruiting
68
Henan Cancer Hospital ( Site 3108)
Zhengzhou, Henan, China, 450008
Actively Recruiting
69
Xiangyang Central Hospital ( Site 3123)
Xiangyang, Hubei, China, 441106
Actively Recruiting
70
Hunan Cancer Hospital ( Site 3134)
Changsha, Hunan, China, 410013
Actively Recruiting
71
Jiangsu Cancer Hospital ( Site 3107)
Nanjing, Jiangsu, China, 210009
Actively Recruiting
72
Jiangsu Province Hospital ( Site 3105)
Nanjing, Jiangsu, China, 210029
Actively Recruiting
73
Nanchang People's Hospital ( Site 3124)
Nanchang, Jiangxi, China, 330025
Actively Recruiting
74
Xi'an International Medical Center Hospital ( Site 3122)
Xi'an, Shaanxi, China, 710100
Actively Recruiting
75
Affiliated Cancer Hospital of Shandong First Medical University ( Site 3115)
Jinan, Shandong, China, 250117
Actively Recruiting
76
Sichuan Cancer Hospital. ( Site 3110)
Chengdu, Sichuan, China, 610041
Actively Recruiting
77
West China Hospital of Sichuan University ( Site 3139)
Chengdu, Sichuan, China, 610041
Actively Recruiting
78
Xinjiang Medical University Cancer Hospital - Urumqi ( Site 3112)
Ürümqi, Xinjiang, China, 830000
Actively Recruiting
79
Sir Run Run Shaw Hospital ( Site 3117)
Hangzhou, Zhejiang, China, 310016
Actively Recruiting
80
Zhejiang Cancer Hospital ( Site 3109)
Hangzhou, Zhejiang, China, 310022
Actively Recruiting
81
Taizhou Hospital of Zhejiang Province ( Site 3137)
Linhai, Zhejiang, China, 317000
Actively Recruiting
82
Instituto de Cancerología-Oncology ( Site 0503)
Medellín, Antioquia, Colombia, 050025
Actively Recruiting
83
FUNDACION CTIC CENTRO DE TRATAMIENTO E INVESTIGACION SOBRE CANCER LUIS CARLOS SARMIENTO ANGULO ( Site 0502)
Bogotá, Bogota D.C., Colombia, 110131
Actively Recruiting
84
Instituto Nacional De Cancerologia ( Site 0504)
Bogotá, Bogota D.C., Colombia, 111511
Actively Recruiting
85
Sociedad De Oncología y Hematología Del Cesar SAS ( Site 0501)
Valledupar, Cesar Department, Colombia, 200001
Actively Recruiting
86
IMAT S.A.S ( Site 0500)
Montería, Departamento de Córdoba, Colombia, 230002
Actively Recruiting
87
CHRU de Brest ( Site 0904)
Brest, Finistere, France, 29200
Actively Recruiting
88
CENTRE LEON BERARD ( Site 0900)
Lyon, Rhone, France, 69008
Actively Recruiting
89
Centre de Lutte Contre le Cancer - Centre Henri Becquerel Normandie Rouen ( Site 0901)
Rouen, Seine-Maritime, France, 76038
Actively Recruiting
90
Gustave Roussy ( Site 0903)
Villejuif, Val-de-Marne, France, 94800
Actively Recruiting
91
Klinikum Lippe Detmold ( Site 1008)
Detmold, North Rhine-Westphalia, Germany, 32756
Actively Recruiting
92
Klinikum Dortmund Klinikzentrum Mitte ( Site 1005)
Dortmund, North Rhine-Westphalia, Germany, 44137
Actively Recruiting
93
Universitaetsklinikum des Saarlandes-Klinik für Frauenheilkunde, Geburtshilfe und Reproduktionsmedi ( Site 1003)
Homburg, Saarland, Germany, 66424
Actively Recruiting
94
General Hospital of Athens "Laiko" ( Site 1105)
Athens, Attica, Greece, 11527
Actively Recruiting
95
Aretaieio Hospital ( Site 1103)
Athens, Attica, Greece, 11528
Actively Recruiting
96
University General Hospital of Heraklion ( Site 1102)
Heraklion, Irakleio, Greece, 71500
Actively Recruiting
97
European Interbalkan Medical Center-Oncology Department ( Site 1101)
Thessaloniki, Greece, 570 01
Actively Recruiting
98
Prince of Wales Hospital ( Site 3301)
Hong Kong, Hong Kong
Actively Recruiting
99
Queen Mary Hospital ( Site 3300)
Pokfulam, Hong Kong
Actively Recruiting
100
Bacs-Kiskun Varmegyei Oktatokorhaz-Onkoradiologiai Kozpont ( Site 1200)
Kecskemét, Bács-Kiskun county, Hungary, 6000
Actively Recruiting
101
Szabolcs Szatmár Bereg Vármegyei Oktatókórház Oncoradiology ( Site 1203)
Nyíregyháza, Szabolcs-Szatmár-Bereg, Hungary, 4400
Actively Recruiting
102
Országos Onkológiai Intézet-B-Belgyógyászati Onkológiai Osztály ( Site 1201)
Budapest, Hungary, 1122
Actively Recruiting
103
Rambam Health Care Campus ( Site 1401)
Haifa, Israel, 3109601
Actively Recruiting
104
Shaare Zedek Medical Center ( Site 1406)
Jerusalem, Israel, 9103102
Actively Recruiting
105
Hadassah Medical Center ( Site 1404)
Jerusalem, Israel, 9112001
Actively Recruiting
106
Sheba Medical Center ( Site 1400)
Ramat Gan, Israel, 5265601
Actively Recruiting
107
Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII ( Site 1507)
Bergamo, Lombardy, Italy, 24127
Actively Recruiting
108
Istituto Europeo di Oncologia IRCCS ( Site 1508)
Milan, Lombardy, Italy, 20141
Actively Recruiting
109
Ospedale San Raffaele. ( Site 1502)
Milan, Italy, 20132
Actively Recruiting
110
Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 1501)
Milan, Italy, 20133
Actively Recruiting
111
Istituto Nazionale Tumori IRCCS Fondazione Pascale-S.C. Oncologia Clinica Sperimentale di Senologia ( Site 1506)
Naples, Italy, 80131
Actively Recruiting
112
Fondazione Policlinico Universitario Agostino Gemelli IRCCS - Università Cattolica del Sacro Cuore ( Site 1500)
Roma, Italy, 00144
Actively Recruiting
113
Aichi Cancer Center ( Site 3200)
Nagoya, Aichi-ken, Japan, 464-8681
Actively Recruiting
114
Nagoya City University Hospital ( Site 3210)
Nagoya, Aichi-ken, Japan, 467-8602
Actively Recruiting
115
National Hospital Organization Hokkaido Cancer Center ( Site 3215)
Sapporo, Hokkaido, Japan, 003-0804
Actively Recruiting
116
Mie University Hospital ( Site 3216)
Tsu, Mie-ken, Japan, 514-8507
Actively Recruiting
117
Kansai Medical University Hospital ( Site 3213)
Hirakata, Osaka, Japan, 573-1191
Actively Recruiting
118
Kindai University Hospital ( Site 3204)
Sakai, Osaka, Japan, 590-0197
Actively Recruiting
119
Shizuoka Cancer Center ( Site 3202)
Sunto-gun, Shizuoka, Japan, 411-8777
Actively Recruiting
120
National Cancer Center Hospital ( Site 3206)
Chūō, Tokyo, Japan, 104-0045
Actively Recruiting
121
Toranomon Hospital ( Site 3205)
Minato, Tokyo, Japan, 105-8470
Actively Recruiting
122
Showa Medical University Hospital ( Site 3209)
Shinagawa, Tokyo, Japan, 142-8666
Actively Recruiting
123
Akita University Hospital ( Site 3207)
Akita, Japan, 010-8543
Actively Recruiting
124
Chiba Cancer Center ( Site 3203)
Chiba, Japan, 260-8717
Actively Recruiting
125
National Hospital Organization Kyushu Cancer Center ( Site 3208)
Fukuoka, Japan, 811-1395
Actively Recruiting
126
Fukushima Medical University Hospital ( Site 3212)
Fukushima, Japan, 960-1295
Actively Recruiting
127
Hiroshima City Hiroshima Citizens Hospital ( Site 3214)
Hiroshima, Japan, 730-8518
Actively Recruiting
128
National Hospital Organization Osaka National Hospital ( Site 3201)
Osaka, Japan, 540-0006
Actively Recruiting
129
CIO - Centro de Inmuno-Oncología de Occidente ( Site 0600)
Guadalajara, Jalisco, Mexico, 44630
Actively Recruiting
130
Hospital Universitario "Dr. Jose Eleuterio Gonzalez" ( Site 0604)
Monterrey, Nuevo León, Mexico, 64460
Actively Recruiting
131
Cuidados Oncologicos. ( Site 0605)
Querétaro City, Querétaro, Mexico, 76000
Actively Recruiting
132
Unidad de Mastologia Avanzada de Chihuahua S.A de C.V ( Site 0602)
Chihuahua City, Mexico, 31123
Actively Recruiting
133
Centro de Investigacion Clinica de Oaxaca ( Site 0601)
Oaxaca City, Mexico, 68020
Actively Recruiting
134
Instituto Regional de Enfermedades Neoplasicas del Centro (IREN CENTRO) ( Site 0702)
Concepción, Departamento de Junín, Peru, 12125
Actively Recruiting
135
Clínica Internacional - Sede San Borja ( Site 0704)
San Borja, Lima region, Peru, 15036
Actively Recruiting
136
IPOR Instituto Peruano de Oncología & Radioterapia ( Site 0701)
San Isidro, Lima region, Peru, 15036
Actively Recruiting
137
Centrum Onkologii im prof Franciszka Lukaszczyka ( Site 1618)
Bydgoszcz, Kuyavian-Pomeranian Voivodeship, Poland, 85-796
Actively Recruiting
138
Narodowy Instytut Onkologii im. Marii Sklodowskiej-Curie ( Site 1600)
Warsaw, Masovian Voivodeship, Poland, 02-781
Actively Recruiting
139
Bialostockie Centrum Onkologii ( Site 1604)
Bialystok, Podlaskie Voivodeship, Poland, 15-027
Actively Recruiting
140
Wojewódzki Szpital Specjalistyczny im. J. Korczaka w Słupsku-Oncologii, Chemioterapii ( Site 1616)
Słupsk, Pomeranian Voivodeship, Poland, 76-200
Actively Recruiting
141
Szpital Kliniczny Ministerstwa Spraw Wewnętrznych i Administracji z Warmińsko-Mazurskim Centrum Onko ( Site 1614)
Olsztyn, Warmian-Masurian Voivodeship, Poland, 10-228
Actively Recruiting
142
Szpital Wojewodzki im.M.Kopernika. ( Site 1607)
Koszalin, West Pomeranian Voivodeship, Poland, 75-581
Actively Recruiting
143
Salve Medica sp. z o.o. sp. k. ( Site 1615)
Lodz, Łódź Voivodeship, Poland, 91-211
Actively Recruiting
144
Seoul National University Bundang Hospital ( Site 2703)
Seongnam, Kyonggi-do, South Korea, 13620
Actively Recruiting
145
Gangnam Severance Hospital, Yonsei University Health System ( Site 2701)
Gangnam-gu, Seoul, South Korea, 06273
Actively Recruiting
146
Samsung Medical Center ( Site 2704)
Gangnam-gu, Seoul, South Korea, 06351
Actively Recruiting
147
Seoul National University Hospital ( Site 2702)
Jongno-Gu, Seoul, South Korea, 03080
Actively Recruiting
148
Severance Hospital Yonsei University Health System ( Site 2700)
Seoul, South Korea, 03722
Actively Recruiting
149
Asan Medical Center ( Site 2705)
Seoul, South Korea, 05505
Actively Recruiting
150
Institut Català d'Oncologia (ICO) - Badalona ( Site 1823)
Badalona, Barcelona, Spain, 08916
Actively Recruiting
151
Hospital Universitario Marques de Valdecilla ( Site 1825)
Santander, Cantabria, Spain, 39008
Actively Recruiting
152
CHUAC-Complejo Hospitalario Universitario A Coruña ( Site 1820)
A Coruña, La Coruna, Spain, 15006
Actively Recruiting
153
Hospital Clinic de Barcelona ( Site 1821)
Barcelona, Spain, 08036
Actively Recruiting
154
Hospital Universitario Ramon y Cajal ( Site 1824)
Madrid, Spain, 28034
Actively Recruiting
155
Hospital Clinico San Carlos... ( Site 1822)
Madrid, Spain, 28040
Actively Recruiting
156
Hospital Universitario Virgen de Valme ( Site 1826)
Seville, Spain, 41014
Actively Recruiting
157
Ditmanson Medical Foundation Chia-Yi Christian Hospital ( Site 2806)
Chiayi City, Chiayi, Taiwan, 600
Actively Recruiting
158
Taichung Veterans General Hospital ( Site 2803)
Taichung, Taiwan, 407
Actively Recruiting
159
National Cheng Kung University Hospital ( Site 2804)
Tainan, Taiwan, 704302
Actively Recruiting
160
Chi-Mei Medical Center ( Site 2805)
Tainan, Taiwan, 710
Actively Recruiting
161
National Taiwan University Hospital ( Site 2800)
Taipei, Taiwan, 10048
Actively Recruiting
162
MacKay Memorial Hospital ( Site 2802)
Taipei, Taiwan, 10449
Actively Recruiting
163
National Taiwan University Cancer Center (NTUCC) ( Site 2801)
Taipei, Taiwan, 106
Actively Recruiting
164
Faculty of Medicine Siriraj Hospital ( Site 2921)
Bangkoknoi, Bangkok, Thailand, 10700
Actively Recruiting
165
Bangkok Metropolitan Administration Medical College and Vajira Hospital ( Site 2924)
Dusit, Bangkok, Thailand, 10300
Actively Recruiting
166
Ramathibodi Hospital. ( Site 2923)
Ratchathewi, Bangkok, Thailand, 10400
Actively Recruiting
167
Songklanagarind Hospital ( Site 2922)
Hat Yai, Changwat Songkhla, Thailand, 90110
Actively Recruiting
168
Maharaj Nakorn Chiang Mai Hospital ( Site 2925)
Muang, Chiang Mai, Thailand, 50200
Actively Recruiting
169
Baskent Universitesi Adana Dr. Turgut Noyan Uygulama ve Arastirma Merkezi ( Site 2107)
Adana, Turkey (Türkiye), 01120
Actively Recruiting
170
Hacettepe Universite Hastaneleri ( Site 2100)
Ankara, Turkey (Türkiye), 06230
Actively Recruiting
171
Memorial Ankara Hastanesi ( Site 2106)
Ankara, Turkey (Türkiye), 06520
Actively Recruiting
172
Gazi University Health Research and Application Center Gazi Hospital ( Site 2101)
Ankara, Turkey (Türkiye), 06560
Actively Recruiting
173
Ankara Bilkent Şehir Hastanesi ( Site 2105)
Ankara, Turkey (Türkiye), 6800
Actively Recruiting
174
Dicle Üniversitesi ( Site 2102)
Diyarbakır, Turkey (Türkiye), 21280
Actively Recruiting
175
Koç Üniversitesi Hastanesi ( Site 2104)
Istanbul, Turkey (Türkiye), 34010
Actively Recruiting
176
Mersin Sehir Eğitim ve Araştırma Hastanesi ( Site 2103)
Mersin, Turkey (Türkiye), 33240
Actively Recruiting
177
Recep Tayyip Erdogan University Training and Research Hospital ( Site 2108)
Rize, Turkey (Türkiye), 53020
Actively Recruiting
178
Samsun Medical Park Hastanesi ( Site 2109)
Samsun, Turkey (Türkiye), 55200
Actively Recruiting
179
University College London Hospital ( Site 2206)
London, England, United Kingdom, NW1 2PG
Actively Recruiting
180
St Bartholomew s Hospital ( Site 2200)
London, London, City of, United Kingdom, EC1A 7BE
Actively Recruiting
181
Leicester Royal Infirmary ( Site 2205)
Leicester, United Kingdom, LE1 5WW
Actively Recruiting
182
The Christie NHS Foundation Trust ( Site 2208)
Manchester, United Kingdom, M20 4BX
Actively Recruiting
Research Team
T
Toll Free Number
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here